We kept our promise
We are back with the 2 nd issue of Onconeph
#Onconephrology
12 🔥 articles
40+ authors
Great collaborative effort
@kdjhaveri
@MegSise
@CharuThakar
@ackdonline
@NKF_NephPros
@nkf
@onconephsociety
@UCKidney
@uofcincy
@UCincyMedicine
@ucincipress
🔥Our editorial speaks about the summary of the individual topics.
Paraproteinemia
TMA $
Na/K ⬇️⬆️in Ca
Palliative Rx
HSCT & kidney
Heme cancer & kidney
Paraneoplastic GN
Sickle cell ds
OncoSx and AKI
Anemia & cancer
Anti Ca Rx dosing in CKD
TxP Onconeph
🔥Kidney in dysproteinemia
Exhaustive review by @HerrmannMd @AkazukiNinaMD Dr Seshan
@MayoClinic @WeillCornell
👉Covers entire spectrum of kidney involvement in dysproteinemias
👉Excellent path images to support the manuscript.
VA by @Elena_Cervants
HSCT and kidney
State of art review @renalmyeloma Ala Abudayeh
@HofstraKidney @MDAndersonNews
👉Covers the entire spectrum of HSCT and kidney involvement
AKI
TMA
CKD
Dialysis
KTx in HSCT pts
VA by @CTeodosiu
Paraneoplastic Glomerular Diseases
by @MayuriTrivedi80 Anushaya Jeyabalan @MGHKidneys
In their review demystify the complex topic of paraneoplastic GN
VA by @nephromythri
Hemat Malignancies & Kidney
AKI most frequently occurs in patients with MM (31.8%), f/b those with leukemia (27.5%)/lymphoma (18.8%)
👉Kidney effects
Prerenal AKI
ATI
Renovascular ds
Infiltration with Ca cells,
Obstruction
GN
Electrolyte / acid base
Sickle Cell Disease & Kidney
by @PAmarapurkar @EmoryUniversity
L Roberts, J Navarrete & F El Rassi
👉Spectacular review on kidney and SCD
Screening & neph ref
novel urinary biomarkers, iron chelation Rx
KRT and KTx in SCD
VA by @DTomacruzMD
TMA $
In dept review on TMA covering all lengths and breaths of this complex topic
@RMHUCINEPHRO @kdjhaveri @kamkalantar @hawkssox et al
@UCIrvine @UChicago @HofstraKidney
VA by @edgarvlermamd
OncoSx-Related AKI
A very innovative article on this topic
🔥 compilation by @kkalra_22, W Zafar, David Ortiz
@GeisingerHealth @DukeKidney
Pathogenesis of AKI is multifactorial & determined by pt & Ca-specific factors
👉AKI most common after Sx for GU Ca
VA by @krithicism
Na & K ⬆️⬇️ in Cancer
P Ratanasrimetha @BetterCallSeeth @bdubNephro
@MGHKidneys @MDAndersonNews
A very systematic case based approach to electrolyte disorders
@TheSkeletonKG
VA by @brian_rifkin
Anemia Rx in the Ca pt with CKD & ESKD
@ArashRashidi14 @pranavgarimella J Thakkar A Al-Asaad,T Kharadjian, MN Torres
@CaseKidneys @ucsdnephrology @EinsteinMed
A controversial topic of anemia Rx in pts with kidney ds & Ca
🔥 summary of guidelines
VA by @sophia_kidney
TxP Onconephrology
@nymurakami Allison Weber @vinaynairdo
@MGHKidneys @UCSFNephrology @HofstraKidney
A very 🔥🔥topic - uptodate r/v
Wait times
Screening of Ca post TxP
IS and Ca risk
PTLD
MM/amyloid & KTx
🐘in the room - ICPI post TxP
VA by @sophia_kidney
Palliative Rx for pts With Ca & Kidney ds
Antonio Corona, @PabloGarciaMD @SammyG
@HofstraKidney @StanfordNeph @MGHKidneys
A very systematic primer of approach to palliative Rx.
🔥Highlights
Unpleasant $ Mx
Discussing prognosis & GOC
End of life care
VA by @SRameshMD
Cancer Drug Dosing in CKD & dialysis
Fantastic review on drug dosing of anti neoplastic agents
@anushreeshirali Ben Sprangers
@YaleNephrology @UZLeuven
🔥🔥 overview of eGFR estimation & pharmacokinetic/ dynamic considerations in patients with CKD
VA by @krithicism
Thank you
🔥All authors & reviewers
🔥Entire VA team @Nephro_Sparks @brian_rifkin @nephromythri @edgarvlermamd @krithicism @sophia_kidney @DTomacruzMD @Elena_Cervants @CTeodosiu @SRameshMD
EIC @ackdonline @CharuThakar
@NKF_NephPros @nkf
@ElsevierConnect @ElsevierNews
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.